Osiris Therapeutics Appoints New Chief Financial Officer and Chief Business Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Osiris Therapeutics (OSIR) Declares $0.20 Special Dividend; 1% Yield
September 17, 2015 8:02 AM EDTOsiris Therapeutics (NASDAQ: OSIR) declared a special dividend of $0.20 per share.
The dividend will be payable on October 30, 2015, to stockholders of record on October 16, 2015.
The annual yield on the dividend is 1 percent.
"We are confident in the financial strength... More
Osiris Therapeutics (OSIR) Names New CFO and CBO
September 17, 2015 8:02 AM EDTOsiris Therapeutics (NASDAQ: OSIR) announced the appointment of Gregory Law, to serve as Chief Financial Officer and Dwayne Montgomery, to serve as Chief Business Officer.
Mr. Law has been employed with Osiris since 2014 as the Vice President of Finance and Principal Accounting Officer. Mr. Law has more than 25 years of finance and accounting experience in a variety of industries, including biotechnology, telecommunications, energy, private equity and consulting. Prior to joining Osiris in 2014, Mr. Law spent over a decade providing consulting services to public and private companies in the areas of interim CFO and controllership,... More
